We used data from a prospective cohort study of patients admitted to an inpatient SUD treatment stay at five treatment centers in central Norway. Patients were recruited in the period from September 2014 to May 2016. Study participation involved providing demographic, substance use and health information, from a questionnaire and the electronic medical record, as well as a follow-up interview 3 months after the end of the inpatient stay. The Regional Ethical Committee for Medical Research in Norway reviewed the study protocol and approved the study (#2013/1733). In accordance with the Declaration of Helsinki, those who agreed to participate gave their signed consent. Dedicated research staff affiliated with the study were responsible for continuously recruiting patients admitted for inpatient treatment at the five clinics. The only exclusion criteria were persons judged mentally incapable of giving their signed consent for participation. Of 728 eligible patients, 611 (84%) consented to participate (see 15, 24 for more details).
Free full text: Click here
